Cancer-associated mis-sense and deletion mutations impair p16(INK4) CDK inhibitory activity

International Journal of Cancer

Volumn 66, Issue 2, 1996, Pages 249-254

  Lilischkis, Richard ^a   Sarcevic, Boris ^a   Kennedy, Catherine ^a   Warlters, Andrea ^a   Sutherland, Robert L ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; HYBRID PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CANCER; CELL CYCLE; DELETION MUTANT; GENE MUTATION; GENETIC POLYMORPHISM; GENOME; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARRIER PROTEINS; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; CYCLINS; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; ONCOGENE PROTEINS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS; SPODOPTERA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029990515     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960410)66:2<249::AID-IJC19>3.0.CO;2-7     Document Type: Article

References (25)

1. CALDAS, C., HAHN, S.A., DA COSTA, L.T., REDSTON, M.S., SCHUTTE, M., SEYMOUR, A.B., WEINSTEIN, C.L., HRUBAN, R.H., YEO, C.J. and KERN, S.E., Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature (Genet.), 8, 27-32 (1994).
2. HANNON, G.J. and BEACH, D., p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature (Lond.), 371, 257-261 (1994).
3. HIRAI, H., ROUSSEL, M.F., KATO, J.Y., ASHMUN, R.A. and SHERR, C.J., Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. cell. Biol., 15, 2672-2681 (1995).
4. HUSSUSSIAN, C.J , STRUEWING, J.P., GOLDSTEIN, A.M., HIGGINS, P.A.T., ALLY, D.S., SHEAHAN, M.D., CLARK, W.H., TUCKER, M.A. and DRACOPOLI, N.C., Germline p16 mutations in familial melanoma. Nature (Genet.), 8, 15-21 (1994).
5. KAELIN, W., JR., PALLAS, D.C., DECAPRIO, J.A., KAYE, F.J. and LIVINGSTON, D.M., Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell, 64, 521-532 (1991).
6. KAMB, A., Cell-cycle regulators and cancer. Trends Genet., 11, 136-140 (1995).
7. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R., JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994a).
8. KAMB, A. and 23 OTHERS, Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature (Genet.), 8, 23-26 (1994b).
9. 1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell, 79, 487-496 (1994).
10. KOH, J., ENDERS, G.H., DYNLACHT, B.D. and HARLOW, E., Tumourderived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (Lond.), 375, 506-510 (1995).
11. LUKAS, J., PARRY, D., AAGAARD, L., MANN, D.J., BARTKOVA, J., STRAUSS, M., PETERS, G. and BARTER, J., Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (Lond.), 375, 503-506 (1995).
12. MATSUOKA, M., KATO, J., FISHER, R.P., MORGAN, D.O. and SHERR, C.J., Activation of cyclin-dependent kinase 4 (CDK4) by mouse MO15-associated kinase. Mol. cell. Biol., 14, 7265-7275 (1994).
13. MEDEMA, R.H., HERRERA, R.E., LAM, F. and WEINBERG, R.A., Growth suppression by p16INK4 requires functional retinoblastoma protein. Proc. nat. Acad, Sci. (Wash.), 92, 6289-6293 (1995).
14. MEYERSON, M., ENDERS, G.H., WU, C.L., SU, L.K., GORKA, C., NELSON, C., HARLOW, E. and TSAI, L.H., A family of human cdc2-related protein kinases. EMBO J., 11, 2909-2917 (1992).
15. MICHAELY, P. and BENNKTT, V., The membrane-binding domain of ankyrin contains four independently folded subdomains, each comprised of six ankyrin repeats. J. biol. Chem., 268, 22703-22709 (1993).
16. MORI, T., MIURA, K., AOKI, T., NISHIHIRA, T., MORI, S. and NAKAMURA, Y., Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54, 3396-3397 (1994).
17. NOBORI, T., MIURA, K., WU, D.J., LOIS, A., TAKABAYASHI, K. and CARSON, D.A., Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368, 753-756 (1994).
18. OGAWA, N., NOGUCHI, K.I., SAWAL, H., YAMASHITA, Y., YOMPAKDEE, C. and OSHIMA, Y., Functional domains of pho81p, an inhibitor of pho85p protein kinase, in the transduction pathway of p-i signals in Saccharomyces cerevisiae. Mol. cell. Biol., 15, 997-1004 (1995).
19. PINES, J., Cyclins and cyclin-dependent kinases: take your partners. Trends biochem. Sci., 18, 195-197 (1993).
20. RANADE, K., HUSSUSSIAN, C.J , SIKORSKI, R.S., VARMUS, H.E., GOLDSTEIN, A.M., TUCKER, M.A., SERRANO, M., HANNON, G.J., BEACH, D. and DRACOPOLI, N.C., Mutations associated with familial melanoma impair p16(ink4) function. Nature (Genet.), 10, 114-116 (1995).
21. SERRANO, M., GOMEZ-LAHOZ, E., DEPINHO, R.A., BEACH, D. and BAR-SAGI, D., Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science, 267, 249-252 (1995).
22. SERRANO, M., HANNON, G.J. and BEACH, D., A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366, 704-707 (1993).
23. SHERR, C.J., D-type cyclins. Trends biol. Sci., 20, 187-190 (1995).
24. WICK, S.T., DUBAY, M.M., IMANIL, I. and BRIZUELA, L., Biochemical and mutagenic analysis of the melanoma tumour suppressor gene product/p16. Oncogene, 11, 2013-2019 (1995).
25. ZHANG, H., HANNON, G.J. and BEACH, D., p21-containing cyclin kinases exist in both active and inactive states. Genes Develop., 8, 1750-1758 (1994).